Meitheal Pharmaceuticals Launches Propofol Injectable Emulsion

Meitheal Pharmaceuticals announced the official launch of Propofol Injectable Emulsion, USP on April 7, 2026. The medication is an intravenous general anesthetic and sedation drug designed for use in surgical and intensive care settings.

The launch introduces the drug in three distinct single-dose vial (SDV) sizes. According to reporting from Pharmacy Times, the availability of these three sizes is intended to help reduce dosing errors and minimize medication waste in clinical environments.

Available Dosage and Product Specifications

Meitheal Pharmaceuticals has released the emulsion in the following configurations:

• Propofol Injectable Emulsion, USP 200 mg per 20 mL SDV (NDC 71288-729-21)
• Propofol Injectable Emulsion, USP 500 mg per 50 mL SDV (NDC 71288-730-51)
• Propofol Injectable Emulsion, USP 1,000 mg per 100 mL SDV (NDC 71288-731-53)

Clinical Indications and Applications

Propofol Injectable Emulsion, USP is indicated for several specific medical applications depending on the patient population and the clinical requirement.

For patients aged 3 years or older, the drug is indicated for the induction of general anesthesia. For patients aged 2 months or older, it is indicated for the maintenance of general anesthesia.

In adult patients, the medication is used for the initiation and maintenance of monitored anesthesia care (MAC) sedation. It is also indicated for adult patients requiring sedation in combination with regional anesthesia.

the drug is indicated for the sedation of adult patients in the intensive care unit (ICU) who are intubated and mechanically ventilated.

Medical Context of Propofol

As an intravenous general anesthetic, propofol is used to induce a state of unconsciousness or deep sedation. Its application in the ICU for mechanically ventilated patients allows for controlled sedation, which is often necessary for patients who cannot breathe independently and require respiratory support.

The use of single-dose vials in these environments is a critical factor in maintaining sterile conditions and ensuring that the correct dosage is administered to the patient without the need for complex calculations or splitting larger vials, which can lead to the waste of the pharmaceutical agent.